Clinical Trial Update: N2O for Acute Suicidality and Depression in the ED [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nitrous oxide for acute suicidality and major depressive disorder in the emergency department has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Nitrous oxide (nitrous oxide)

Snippet

Sponsor: University of Chicago | Conditions: Suicidal Ideation, Major Depressive Disorder | Phase 2 | Status: WITHDRAWN